The positive effects on AD mouse models seen with LA1011 treatment and the ability of LA1011 to prevent FKBP51 interaction with Hsp90 corroborate the importance of FKBP51 in driving tauopathies.23 Here, HSP90AA1 is linked to tauopathy.